52 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd.
11 Sep 24
Notice of Annual General Meeting of Shareholders
8:30am
Regarding Compensation and Expense Reimbursement of External Directors), 2000. For details regarding Mr. Novik’s compensation, as currently in effect
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd.
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including
424B5
ENLV
Enlivex Therapeutics Ltd.
29 May 24
Prospectus supplement for primary offering
4:15pm
product candidates;
third-party payer reimbursement for our current or any future product candidates;
our estimates regarding anticipated expenses
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd.
29 Mar 24
Report of Foreign Private Issuer
4:30pm
associated with the ongoing sepsis clinical Phase II trial.
In January 2021, the Company submitted a new grant application to the IIA for reimbursement
6-K
EX-99.1
3mo1ptra5 ug6t
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
pr91e
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
ehong8 98bnsmp96
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
orf 9uf1joo9k7n
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
02dkrdrcbg1yg
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
prbs xtvo4uh
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
F-3
tn3 4pp3c
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
6job2lgv 284
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
2fpcmm4
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
q7pdk6sj9 7js
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.1
wctn0q2
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.1
cf7xxi9a
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am